Reply to: Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis".
作者信息
Dobry Allison S, Quesenberry Charles P, Asgari Maryam M
机构信息
Department of Medicine, Cambridge Health Alliance, Cambridge, Massachusetts.
Division of Research, Kaiser Permanente Northern California, Oakland, California.
出版信息
J Am Acad Dermatol. 2018 May;78(5):e115. doi: 10.1016/j.jaad.2017.12.017. Epub 2017 Dec 14.
Abstract
摘要
相似文献
1
Reply to: Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis".回复：对“一大群接受全身治疗的银屑病患者中的严重感染”的评论
J Am Acad Dermatol. 2018 May;78(5):e115. doi: 10.1016/j.jaad.2017.12.017. Epub 2017 Dec 14.
2
Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis".关于“一大群接受全身治疗的银屑病患者中的严重感染”的评论
J Am Acad Dermatol. 2018 May;78(5):e113-e114. doi: 10.1016/j.jaad.2017.10.054. Epub 2018 Jan 5.
3
Serious infections among a large cohort of subjects with systemically treated psoriasis.一大群接受全身治疗的银屑病患者中的严重感染
J Am Acad Dermatol. 2017 Nov;77(5):838-844. doi: 10.1016/j.jaad.2017.07.047. Epub 2017 Sep 13.
4
Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.在一个管理式医疗人群中，对大量接受系统性治疗的银屑病患者进行的恶性肿瘤发生率研究。
J Am Acad Dermatol. 2017 Apr;76(4):632-638. doi: 10.1016/j.jaad.2016.10.006. Epub 2017 Feb 3.
5
Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis.带状疱疹在接受系统性治疗的银屑病大队列患者中的发生率。
JAMA Dermatol. 2018 Feb 1;154(2):218-219. doi: 10.1001/jamadermatol.2017.4840.
6
Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort.银屑病患者住院治疗感染性疾病的风险增加：一项基于人群的队列研究。
J Am Acad Dermatol. 2011 Dec;65(6):1135-44. doi: 10.1016/j.jaad.2010.08.036. Epub 2011 Jun 12.
7
Response to 'Reply to Gohar on "Lungs, methotrexate and psoriasis", a comment on "Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis"'.对《关于“肺、甲氨蝶呤与银屑病”对〈一名接受长期低剂量甲氨蝶呤治疗银屑病的患者发生致命性、偶然性、特发性肺纤维化〉的回复》的回应
Clin Exp Dermatol. 2019 Dec;44(8):948. doi: 10.1111/ced.14002. Epub 2019 May 6.
8
Reply to Gohar on 'Lungs, methotrexate and psoriasis', a comment on 'Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis'.
Clin Exp Dermatol. 2019 Jul;44(5):595. doi: 10.1111/ced.13994. Epub 2019 May 17.
9
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).银屑病的生物制剂和系统治疗的严重感染风险：来自银屑病纵向评估和登记研究（PSOLAR）的结果。
JAMA Dermatol. 2015 Sep;151(9):961-9. doi: 10.1001/jamadermatol.2015.0718.
10
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.回复：对于合并乙型或丙型肝炎感染的银屑病患者，阿达木单抗是一种安全的选择：一项对37例患者的多中心队列研究及文献综述
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e486. doi: 10.1111/jdv.14300. Epub 2017 May 15.
本文引用的文献
1
Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis".关于“一大群接受全身治疗的银屑病患者中的严重感染”的评论
J Am Acad Dermatol. 2018 May;78(5):e113-e114. doi: 10.1016/j.jaad.2017.10.054. Epub 2018 Jan 5.
2
Serious infections among a large cohort of subjects with systemically treated psoriasis.一大群接受全身治疗的银屑病患者中的严重感染
J Am Acad Dermatol. 2017 Nov;77(5):838-844. doi: 10.1016/j.jaad.2017.07.047. Epub 2017 Sep 13.
3
Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis.甲氨蝶呤初治银屑病患者中，甲氨蝶呤与阿普米司特的疗效比较和应答者增量成本。
J Am Acad Dermatol. 2016 Oct;75(4):740-746. doi: 10.1016/j.jaad.2016.05.040. Epub 2016 Jul 28.
4
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.在临床实践中常用的全身治疗或光疗对中度至重度斑块状银屑病的比较疗效。
Arch Dermatol. 2012 Apr;148(4):487-94. doi: 10.1001/archdermatol.2012.370.
Zotero 插件